Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
WFaBwHSMthUC27Eg
Écouter
